ArticleJTCVS open2026
Patients with asymptomatic severe mitral regurgitation already have abnormal left ventricular myocardial sarcomeric ultrastructural characteristics.
Article in JTCVS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Mitral valve (MV) surgery remains a class I recommendation for patients with symptomatic severe primary mitral regurgitation (PMR). For asymptomatic patients with severe PMR and preserved left ventricular (LV) function without atrial fibrillation, pulmonary hypertension, or significant left atrial enlargement, surgical treatment is not currently recommended. However, the nature and extent of LV myocardial ultrastructural alterations in patients who are asymptomatic remain unclear. Methods: Twelve patients with severe PMR were enrolled in this study, 8 of whom were symptomatic and 4 asymptomatic. Three donor hearts were used as controls. LV biopsies were obtained and processed for transmission electron microscopy. Transmission electron microscopy images were acquired from 600× to 25,000× magnification. Quantitative analysis was performed using the ImageJ software. Statistical comparisons were made using a linear mixed-effects model to account for repeated measurements within individuals. Post-hoc pairwise comparisons were conducted using Bonferroni correction. Statistical significance was defined as Results: Qualitatively, myofibrillar disarray, reduced cytoplasmic reserve, and mitochondrial derangement were observed in patients with severe PMR, regardless of presence of symptoms, compared with controls. Quantitatively, the sarcomere length was greater in control patients (1.65 ± 0.23 μm) compared with those who were symptomatic (1.31 ± 0.34 μm, Conclusions: In patients with severe asymptomatic PMR and preserved LV function without atrial fibrillation, pulmonary hypertension, or significant left atrial enlargement, ultrastructural alterations of the LV myocardium are already evident and comparable with those observed in severe symptomatic PMR. These findings suggest that early surgical intervention in patients who are asymptomatic with severe PMR may help prevent further adverse remodeling and potentially improve clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.